Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Durukan

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Impotence Research|March 23, 2024
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study"Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Sexual Medicine Reviews|October 30, 2023
The association between Peyronie's disease and depression: a scoping reviewRune Kraglund, Emil Durukan, Annamaria Giraldi, et al.
International Journal of Impotence Research|June 27, 2023
Quality and benefits of the erectile dysfunction information on websites, social-media, and applicationsGiorgio Ivan Russo, Maria Giovanna Asmundo, Emil Durukan, et al.
International Journal of Impotence Research|January 16, 2024
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort studyEmil Durukan, Rune Kraglund, Shad Azad Rashid, et al.
International Urology and Nephrology|November 27, 2025
Impact of androgen deprivation therapy and androgen receptor pathway inhibitors on cardiac structure and function evaluated by echocardiography in males with prostate cancer: a systematic review and meta-analysisBjørn Rørbæk Kemp, Emil Durukan, Kristoffer Grundtvig Skaarup, et al.
World Journal of Urology|May 29, 2024
Platelet-rich plasma therapy in erectile dysfunction and Peyronie's disease: a systematic review of the literatureMaria Giovanna Asmundo, Emil Durukan, Elena von Rohden, et al.
International Journal of Impotence Research|April 20, 2026
Response to Comment on: Penile vibratory stimulation as rehabilitation of erectile function following nerve-sparing radical prostatectomy: a quantitative pilot studyHelene Reif Andersen, Alexander Bjørneboe Nolsøe, Emil Durukan, et al.
International Journal of Impotence Research|April 14, 2026
Penile vibratory stimulation as rehabilitation of erectile function following nerve-sparing radical prostatectomy: A quantitative pilot studyHelene Reif Andersen, Alexander Bjørneboe Nolsøe, Emil Durukan, et al.
European Urology Focus|June 5, 2024
Data Availability Statements and Data Sharing in Urology: A False Promise?Maria Giovanna Asmundo, Emil Durukan, Giorgio Ivan Russo, et al.
European Urology Focus|June 24, 2023
Erectile Dysfunction Is Associated with Left Ventricular Diastolic Dysfunction: A Systematic Review and Meta-analysisEmil Durukan, Christian Fuglesang S Jensen, Kristoffer Grundtvig Skaarup, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Impotence Research|March 23, 2024
Response to: "Commentary on: phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's disease: a retrospective cohort study"Emil Durukan, Christian Fuglesang Skjødt Jensen, Mikkel Fode
Sexual Medicine Reviews|October 30, 2023
The association between Peyronie's disease and depression: a scoping reviewRune Kraglund, Emil Durukan, Annamaria Giraldi, et al.
International Journal of Impotence Research|June 27, 2023
Quality and benefits of the erectile dysfunction information on websites, social-media, and applicationsGiorgio Ivan Russo, Maria Giovanna Asmundo, Emil Durukan, et al.
International Journal of Impotence Research|January 16, 2024
Phosphodiesterase type 5 inhibitors do not prevent curvature progression but shorten pain duration in the active phase of Peyronie's Disease: A retrospective cohort studyEmil Durukan, Rune Kraglund, Shad Azad Rashid, et al.
International Urology and Nephrology|November 27, 2025
Impact of androgen deprivation therapy and androgen receptor pathway inhibitors on cardiac structure and function evaluated by echocardiography in males with prostate cancer: a systematic review and meta-analysisBjørn Rørbæk Kemp, Emil Durukan, Kristoffer Grundtvig Skaarup, et al.
World Journal of Urology|May 29, 2024
Platelet-rich plasma therapy in erectile dysfunction and Peyronie's disease: a systematic review of the literatureMaria Giovanna Asmundo, Emil Durukan, Elena von Rohden, et al.
International Journal of Impotence Research|April 20, 2026
Response to Comment on: Penile vibratory stimulation as rehabilitation of erectile function following nerve-sparing radical prostatectomy: a quantitative pilot studyHelene Reif Andersen, Alexander Bjørneboe Nolsøe, Emil Durukan, et al.
International Journal of Impotence Research|April 14, 2026
Penile vibratory stimulation as rehabilitation of erectile function following nerve-sparing radical prostatectomy: A quantitative pilot studyHelene Reif Andersen, Alexander Bjørneboe Nolsøe, Emil Durukan, et al.
European Urology Focus|June 5, 2024
Data Availability Statements and Data Sharing in Urology: A False Promise?Maria Giovanna Asmundo, Emil Durukan, Giorgio Ivan Russo, et al.
European Urology Focus|June 24, 2023
Erectile Dysfunction Is Associated with Left Ventricular Diastolic Dysfunction: A Systematic Review and Meta-analysisEmil Durukan, Christian Fuglesang S Jensen, Kristoffer Grundtvig Skaarup, et al.
Pageof 3